Global Neglected Tropical Diseases Diagnosis Market is valued at approximately USD 6.9 Million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2022-2028. Neglected tropical diseases (NTDs) are infections caused by viruses, bacteria, or parasites that are common in low-income populations and affect poor people all over the world. These untreated tropical diseases are also associated with high levels of morbidity due to the pathogens' chronic existence. The increasing adoption of point-of-care testing services in home healthcare, rising demand for rapid diagnostic tests for the treatment of lymphatic filariasis, and increasing continuous efforts by healthcare companies to develop less complicated disease diagnostic platforms are the factors expected to drive the growth of the Neglected Tropical Diseases Diagnosis Market during the forecast period. According to WHO estimates, more than 1.7 billion people, or about one-fifth of the world's population, needed treatment for at least one NTD each year, mostly in low-income and developing countries. NTDs affected approximately 40% of the African continent. These diseases are more common among the poor who live in tropical climates and difficult-to-reach areas. However, low level of awareness of contagious disease prevention and treatment in underdeveloped areas, as well as a lack of favourable reimbursement policies, are limiting the market growth. Moreover, various WHO initiatives, such as the road map 2030 for the elimination of NTDs, are expected to drive market growth over the forecast period. Government agencies like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) work with counties to improve public health services for NTDs. Furthermore, the WHO released its NTDs roadmap for the years 2021 to 2030 in January 2021. Its goal is to improve global prevention and control of neglected tropical diseases. During the forecast period, government initiatives are expected to drive market growth.
The key regions considered for the global Neglected Tropical Diseases Diagnosis market study include: Asia Pacific, North America, Europe, Latin America, and Rest of the World. Geographically, the North American Neglected Tropical Diseases Diagnosis Market had the highest revenue share and it is expected to continue dominating between 2022 and 2028, owing to the rising demand for rapid diagnostic tests for lymphatic filariasis treatment. Whereas, because of increased IVD product penetration and the high disease burden of NTDs in developing countries in the region, Latin America is expected to have the fastest CAGR over the forecast period. Furthermore, increased government spending, the presence of skilled healthcare professionals, and multinational diagnostic companies' increased focus on the development of advanced and novel IVD products are among the factors likely to drive market growth in Latin America.
ByMajor market players included in this report are:
- F. Hoffmann-La Roche Ltd
- Abbott
- Thermo Fisher Scientific Inc.
- ZeptoMetrix
- InBios International, Inc.
- Genome Diagnostics Pvt. Ltd.
- Omega Diagnostics Group PLC
- Coris BioConcept
- DiaSys Diagnostic Systems GmbH
- Oscar Medicare Pvt Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Disease:
- Dengue
- Chikungunya
- Rabies
- Leprosy
- Buruli Ulcer
- Yaws
- Lymphatic Filariasis
- Taeniasis/Cysticercosis
- Foodborne Trematodiases
- Echinococcosis
- Chagas Disease (American Trypanosomiasis)
- Dracunculiasis
- African Trypanosomiasis
- Soil-transmitted Helminth Infections
- Onchocerciasis
- Schistosomiasis
- Scabies and Other Ectoparasites
- Snakebite Envenoming
- Leishmaniasis
By Diagnostic:
- Conventional Method
- Molecular/Modern Method
By Service Type:
- Centralized Service
- POC Service
By End-Use:
- Clinical Labs
- Hospitals /Clinics
- Home Healthcare
By Region:
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
ByFurthermore, years considered for the study are as follows:
- Historical year - 2018, 2019, 2020
- Base year - 2021
- Forecast period - 2022 to 2028
ByTarget Audience of the Global Neglected Tropical Diseases Diagnosis Market in Market Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
- 1.2.1. Neglected Tropical Diseases Diagnosis Market, by Region, 2020-2028 (USD Million)
- 1.2.2. Neglected Tropical Diseases Diagnosis Market, by Disease, 2020-2028 (USD Million)
- 1.2.3. Neglected Tropical Diseases Diagnosis Market, by End-use, 2020-2028 (USD Million)
- 1.2.4. Neglected Tropical Diseases Diagnosis Market, by Diagnostic, 2020-2028 (USD Million)
- 1.2.5. Neglected Tropical Diseases Diagnosis Market, by Service Type, 2020-2028 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Neglected Tropical Diseases Diagnosis Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Neglected Tropical Diseases Diagnosis Market Dynamics
- 3.1. Neglected Tropical Diseases Diagnosis Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Rise in the adoption of point-of-care testing
- 3.1.1.2. Rising concern regarding Neglected Tropical Diseases (NTD)
- 3.1.2. Market Challenges
- 3.1.2.1. High cost for diagnosis
- 3.1.3. Market Opportunities
- 3.1.3.1. Growing demand for rapid diagnostic tests for the treatment of lymphatic filariasis
Chapter 4. Global Neglected Tropical Diseases Diagnosis Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Neglected Tropical Diseases Diagnosis Market, by Disease
- 6.1. Market Snapshot
- 6.2. Global Neglected Tropical Diseases Diagnosis Market by Disease, Performance - Potential Analysis
- 6.3. Global Neglected Tropical Diseases Diagnosis Market Estimates & Forecasts by Disease, 2018-2028 (USD Million)
- 6.4. Neglected Tropical Diseases Diagnosis Market, Sub Segment Analysis
- 6.4.1. Dengue
- 6.4.2. Chikungunya
- 6.4.3. Rabies
- 6.4.4. Leprosy
- 6.4.5. Buruli Ulcer
- 6.4.6. Yaws
- 6.4.7. Lymphatic Filariasis
- 6.4.8. Taeniasis/Cysticercosis
- 6.4.9. Foodborne Trematodiases
- 6.4.10. Echinococcosis
- 6.4.11. Chagas Disease (American Trypanosomiasis)
- 6.4.12. Dracunculiasis
- 6.4.13. African Trypanosomiasis
- 6.4.14. Soil-transmitted Helminth Infections
- 6.4.15. Onchocerciasis
- 6.4.16. Schistosomiasis
- 6.4.17. Scabies and Other Ectoparasites
- 6.4.18. Snakebite Envenoming
- 6.4.19. Leishmaniasis
Chapter 7. Global Neglected Tropical Diseases Diagnosis Market, by End-use
- 7.1. Market Snapshot
- 7.2. Global Neglected Tropical Diseases Diagnosis Market by End-use, Performance - Potential Analysis
- 7.3. Global Neglected Tropical Diseases Diagnosis Market Estimates & Forecasts by End-use, 2018-2028 (USD Million)
- 7.4. Neglected Tropical Diseases Diagnosis Market, Sub Segment Analysis
- 7.4.1. Clinical Labs
- 7.4.2. Hospitals /Clinics
- 7.4.3. Home Healthcare
Chapter 8. Global Neglected Tropical Diseases Diagnosis Market, by Diagnostic
- 8.1. Market Snapshot
- 8.2. Global Neglected Tropical Diseases Diagnosis Market by Diagnostic, Performance - Potential Analysis
- 8.3. Global Neglected Tropical Diseases Diagnosis Market Estimates & Forecasts by Diagnostic, 2018-2028 (USD Million)
- 8.4. Neglected Tropical Diseases Diagnosis Market, Sub Segment Analysis
- 8.4.1. Conventional Method
- 8.4.2. Molecular/Modern Method
Chapter 9. Global Neglected Tropical Diseases Diagnosis Market, by Service Type
- 9.1. Market Snapshot
- 9.2. Global Neglected Tropical Diseases Diagnosis Market by Service Type, Performance - Potential Analysis
- 9.3. Global Neglected Tropical Diseases Diagnosis Market Estimates & Forecasts by Service Type, 2018-2028 (USD Million)
- 9.4. Neglected Tropical Diseases Diagnosis Market, Sub Segment Analysis
- 9.4.1. Centralized Service
- 9.4.2. POC Service
Chapter 10. Global Neglected Tropical Diseases Diagnosis Market, Regional Analysis
- 10.1. Neglected Tropical Diseases Diagnosis Market, Regional Market Snapshot
- 10.2. North America Neglected Tropical Diseases Diagnosis Market
- 10.2.1. U.S. Neglected Tropical Diseases Diagnosis Market
- 10.2.1.1. Disease breakdown estimates & forecasts, 2018-2028
- 10.2.1.2. End-use breakdown estimates & forecasts, 2018-2028
- 10.2.1.3. Diagnostic breakdown estimates & forecasts, 2018-2028
- 10.2.1.4. Service Type breakdown estimates & forecasts, 2018-2028
- 10.2.2. Canada Neglected Tropical Diseases Diagnosis Market
- 10.3. Europe Neglected Tropical Diseases Diagnosis Market Snapshot
- 10.3.1. U.K. Neglected Tropical Diseases Diagnosis Market
- 10.3.2. Germany Neglected Tropical Diseases Diagnosis Market
- 10.3.3. France Neglected Tropical Diseases Diagnosis Market
- 10.3.4. Spain Neglected Tropical Diseases Diagnosis Market
- 10.3.5. Italy Neglected Tropical Diseases Diagnosis Market
- 10.3.6. Rest of Europe Neglected Tropical Diseases Diagnosis Market
- 10.4. Asia-Pacific Neglected Tropical Diseases Diagnosis Market Snapshot
- 10.4.1. China Neglected Tropical Diseases Diagnosis Market
- 10.4.2. India Neglected Tropical Diseases Diagnosis Market
- 10.4.3. Japan Neglected Tropical Diseases Diagnosis Market
- 10.4.4. Australia Neglected Tropical Diseases Diagnosis Market
- 10.4.5. South Korea Neglected Tropical Diseases Diagnosis Market
- 10.4.6. Rest of Asia Pacific Neglected Tropical Diseases Diagnosis Market
- 10.5. Latin America Neglected Tropical Diseases Diagnosis Market Snapshot
- 10.5.1. Brazil Neglected Tropical Diseases Diagnosis Market
- 10.5.2. Mexico Neglected Tropical Diseases Diagnosis Market
- 10.6. Rest of The World Neglected Tropical Diseases Diagnosis Market
Chapter 11. Competitive Intelligence
- 11.1. Top Market Strategies
- 11.2. Company Profiles
- 11.2.1. F. Hoffmann-La Roche Ltd
- 11.2.1.1. Key Information
- 11.2.1.2. Overview
- 11.2.1.3. Financial (Subject to Data Availability)
- 11.2.1.4. End-use Summary
- 11.2.1.5. Recent Developments
- 11.2.2. Abbott
- 11.2.3. Thermo Fisher Scientific Inc.
- 11.2.4. ZeptoMetrix
- 11.2.5. InBios International, Inc.
- 11.2.6. Genome Diagnostics Pvt. Ltd.
- 11.2.7. Omega Diagnostics Group PLC
- 11.2.8. Coris BioConcept
- 11.2.9. DiaSys Diagnostic Systems GmbH
- 11.2.10. Oscar Medicare Pvt Ltd.
Chapter 12. Research Process
- 12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
- 12.2. Research Attributes
- 12.3. Research Assumption